0.63
3.02%
-0.0196
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
VBI Vaccines Inc. Borsa (VBIV) Ultime notizie
Has VBI Vaccines (VBIV) Outpaced Other Medical Stocks This Year? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
3-Antigen Hepatitis B Vaccine Successfully Scales — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
VBI Vaccines' Revenue Soars, Promising Vaccine Trials - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Updates Share Sale Agreements and Partnerships - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Reports First Quarter 2024 Financial Results - Business Wire
Business Wire
VBI Vaccines, Inc. (VBIV) Upgraded to Strong Buy: Here's Why - Yahoo Movies UK
Yahoo Movies UK
StockNews.com Initiates Coverage on VBI Vaccines (NASDAQ:VBIV) - Defense World
Defense World
VBI Vaccines (NASDAQ:VBIV) Research Coverage Started at StockNews.com - Defense World
Defense World
VBI Vaccines (NASDAQ:VBIV) Receives New Coverage from Analysts at StockNews.com - Defense World
Defense World
VBI Vaccines Soars with Hepatitis B Vaccine Success - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Reports Full Year 2023 Financial Results - Business Wire
Business Wire
3-antigen Hepatitis B Vaccine Reports Positive Early 2024 Results - Precision Vaccinations
Precision Vaccinations
It would be worthwhile to take a closer look at VBI Vaccines Inc. (VBIV) – US Post News - US Post News
US Post News
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Markets Insider
Markets Insider
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
VBI-1901 shows promise in glioblastoma study By Investing.com - Investing.com
Investing.com
VBI Vaccines Boosts Canadian Govt Partnership - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Bolsters Collaboration with Canadian Government - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched ... - Business Wire
Business Wire
VBI Vaccines signs agreement with Canada to develop COVID-19 vaccine by 2022 - Yahoo News Australia
Yahoo News Australia
Scientists search for a universal coronavirus vaccine - upworthyscience.com
upworthyscience.com
Vaccine News — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo ... - Marketscreener.com
Marketscreener.com
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
VBI Vaccines Advances Strategy with Key Financial Moves - TipRanks.com - TipRanks
TipRanks
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
Late-stage Hepatitis B Virus Development Programs Enter New Agreements - Precision Vaccinations
Precision Vaccinations
Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate ... - PR Newswire
PR Newswire
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
VBI-1901 Demonstrates Encouraging Clinical Activity in Recurrent GBM - Targeted Oncology
Targeted Oncology
VBI Vaccines Reports Third Quarter 2023 Financial Results - VBI Vaccines
VBI Vaccines
VBI Vaccines announces mRNA-launched eVLP technology - BioWorld Online
BioWorld Online
VBI Vaccines' pan-coronavirus vaccine candidate produced broad protection against COVID variants of concern - MarketWatch
MarketWatch
VBI Vaccines Reports Second Quarter 2023 Financial Results - VBI Vaccines
VBI Vaccines
Brii expands hepatitis B partnership with VBI in deal worth $437M - BioWorld Online
BioWorld Online
Why Is VBI Vaccines (VBIV) Stock Down 40% Today? - InvestorPlace
InvestorPlace
VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in ... - Business Wire
Business Wire
VBI Vaccines Reports First Quarter 2023 Financial Results - VBI Vaccines
VBI Vaccines
VBI Vaccines stock falls on portfolio overhaul, reverse stock split - Seeking Alpha
Seeking Alpha
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Misses Revenue Estimates - Yahoo News UK
Yahoo News UK
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in ... - Business Wire
Business Wire
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri® - Valneva
Valneva
VBI Vaccines Reports Second Quarter 2022 Financial Results and Provides Corporate Update - VBI Vaccines
VBI Vaccines
VBI Vaccines Inc (NASDAQ: VBIV) Receives Orphan Drug Designation For VBI-1901 for Glioblastoma Treatment - BP Journal
BP Journal
VBI Vaccines Announces New Data and Progress of VBI-2900, VBI's eVLP Coronavirus Program - Business Wire
Business Wire
VBI Vaccines Announces FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults - Business Wire
Business Wire
VBIV Stock: Hepatitis Vaccine Approval Can Be Valuation Catalyst - Seeking Alpha
Seeking Alpha
Three Antigen Hepatitis B Vaccine Found Effective — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
Capitalizzazione:
|
Volume (24 ore):